Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple MyelomaTONG, Wei-Gang; RONG CHEN; MAHADOCON, Kristi et al.Journal of clinical oncology. 2010, Vol 28, Num 18, pp 3015-3022, issn 0732-183X, 8 p.Article

Farnesyl Transferase Expression Determines Clinical Response to the Docetaxel-Lonafarnib Combination in Patients With Advanced MalignanciesKAUH, John; CHANEL-VOS, Chantal; RAMALINGAM, Suresh S et al.Cancer. 2011, Vol 117, Num 17, pp 4049-4059, issn 0008-543X, 11 p.Article

A Phase I/II Trial Combining High-Dose Melphalan and Autologous Transplant with Bortezomib for Multiple Myeloma: A Dose- and Schedule-Finding StudyLONIAL, Sagar; KAUFMAN, Jonathan; LECHOWICZ, Mary J et al.Clinical cancer research (Print). 2010, Vol 16, Num 20, pp 5079-5086, issn 1078-0432, 8 p.Article

Phase I Study of Pazopanib in Patients with Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group StudySHIBATA, Stephen I; CHUNG, Vincent; O'NEIL, Bert H et al.Clinical cancer research (Print). 2013, Vol 19, Num 13, pp 3631-3639, issn 1078-0432, 9 p.Article

Phase 1 and Pharmacokinetic Study of Everolimus, a Mammalian Target of Rapamycin Inhibitor, in Combination With Docetaxel for Recurrent/Refractory Nonsmall Cell Lung CancerRAMALINGAM, Suresh S; HARVEY, R. Donald; HAIAN FU et al.Cancer. 2010, Vol 116, Num 16, pp 3903-3909, issn 0008-543X, 7 p.Article

Subcutaneous Versus Intravenous Bortezomib: Efficiency Practice Variables and Patient PreferencesBARBEE, Meagan S; HARVEY, R. Donald; LONIAL, Sagar et al.The Annals of pharmacotherapy. 2013, Vol 47, Num 9, pp 1136-1142, issn 1060-0280, 7 p.Article

Therapeutic Misconception, Misestimation, and Optimism in Participants Enrolled in Phase 1 TrialsPENTZ, Rebecca D; WHITE, Margaret; HARVEY, R. Donald et al.Cancer. 2012, Vol 118, Num 18, pp 4571-4578, issn 0008-543X, 8 p.Article

Phase I Study of Vorinostat in Patients With Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group StudyRAMALINGAM, Suresh S; KUMMAR, Shivaani; IVY, S. Percy et al.Journal of clinical oncology. 2010, Vol 28, Num 29, pp 4507-4512, issn 0732-183X, 6 p.Article